Lin, Q.; Liu, F.; Ma, Y.; Li, Y.; Lin, T.; Chen, X.; Zhang, J.; Sun, H.; Wang, Z.; Xia, X.;
et al. TCR-T Cell Recognition of an NY-ESO-1 Epitope Presented by HLA-A2 Supertype: Implications for Cancer Immunotherapy. Vaccines 2025, 13, 898.
https://doi.org/10.3390/vaccines13090898
AMA Style
Lin Q, Liu F, Ma Y, Li Y, Lin T, Chen X, Zhang J, Sun H, Wang Z, Xia X,
et al. TCR-T Cell Recognition of an NY-ESO-1 Epitope Presented by HLA-A2 Supertype: Implications for Cancer Immunotherapy. Vaccines. 2025; 13(9):898.
https://doi.org/10.3390/vaccines13090898
Chicago/Turabian Style
Lin, Qingqing, Fenglan Liu, Yipeng Ma, Yanwei Li, Tong Lin, Xiaochun Chen, Jinling Zhang, Heng Sun, Zhi Wang, Xiaojun Xia,
and et al. 2025. "TCR-T Cell Recognition of an NY-ESO-1 Epitope Presented by HLA-A2 Supertype: Implications for Cancer Immunotherapy" Vaccines 13, no. 9: 898.
https://doi.org/10.3390/vaccines13090898
APA Style
Lin, Q., Liu, F., Ma, Y., Li, Y., Lin, T., Chen, X., Zhang, J., Sun, H., Wang, Z., Xia, X., Tian, G., Jin, S., & Wang, M.
(2025). TCR-T Cell Recognition of an NY-ESO-1 Epitope Presented by HLA-A2 Supertype: Implications for Cancer Immunotherapy. Vaccines, 13(9), 898.
https://doi.org/10.3390/vaccines13090898